Lpl Financial LLC Sorrento Therapeutics, Inc. Transaction History

Lpl Financial LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.74 - $1.83 $3,876 - $9,585	-5,238 Reduced 4.59%	108,865 $96,000
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $3,694 - $7,047	-2,447 Reduced 2.1%	114,103 $179,000
Q2 2022 Aug 12, 2022	BUY	$1.24 - $2.33 $10,101 - $18,980	8,146 Added 7.51%	116,550 $234,000
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $47,742 - $116,967	23,871 Added 28.24%	108,404 $253,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $126,480 - $196,656	-27,200 Reduced 24.34%	84,533 $393,000
Q3 2021 Nov 15, 2021	SELL	$7.41 - $10.99 $19,102 - $28,332	-2,578 Reduced 2.26%	111,733 $853,000
Q2 2021 Aug 13, 2021	BUY	$6.35 - $10.0 $89,960 - $141,670	14,167 Added 14.15%	114,311 $1.11 Million
Q1 2021 May 14, 2021	SELL	$7.03 - $16.51 $559,609 - $1.31 Million	-79,603 Reduced 44.29%	100,144 $828,000
Q4 2020 Feb 12, 2021	BUY	$5.76 - $11.95 $44,760 - $92,863	7,771 Added 4.52%	179,747 $1.23 Million
Q3 2020 Nov 09, 2020	SELL	$6.17 - $18.82 $672,961 - $2.05 Million	-109,070 Reduced 38.81%	171,976 $1.92 Million
Q2 2020 Aug 13, 2020	BUY	$1.73 - $6.76 $459,204 - $1.79 Million	265,436 Added 1700.42%	281,046 $1.77 Million
Q1 2020 May 14, 2020	BUY	$1.57 - $4.76 $24,507 - $74,303	15,610 New	15,610 $29,000

5.48M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.